StockData

Harte Hanks vs Stran &

HHS and SWAG side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How HHS and SWAG compare

Harte Hanks is the larger company, worth 1.3 times as much as Stran & ($28.0M against $21.6M).

Stran & grew revenue faster over the last twelve months (10.3% versus −11.6% for Harte Hanks).

Stran & keeps more of each dollar of sales as profit, with a net margin of 0.05% compared with −3.7% at Harte Hanks.

Stran & scores higher on the StockData Score (11 against 5 for Harte Hanks), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricHHSSWAG
Size and price
Market cap$28.0M$21.6M
Share price$3.76$1.16
Change, 1 year26.2%−58.1%
Change, 5 years−53.0%−62.9%
Beta (5Y)2.390.57
Employees1,719154
StockData Score
Total score511 (better)
Valuation score11
Growth score02 (better)
Performance score03 (better)
Health score45 (better)
Dividend score00
Valuation
P/S0.2×0.2× (better)
P/B1.8×0.7× (better)
EV/EBITDA–106×
FCF yield−5.2% (better)−19.9%
Fair value–$0.877
Margin of safety–−32.3%
Growth
Revenue growth (TTM)−11.6%10.3% (better)
Revenue growth, 5Y average−2.0%25.2% (better)
Profitability
Gross margin–29.7%
Operating margin−3.1%−0.91% (better)
Net margin−3.7%0.05% (better)
FCF margin−0.94% (better)−3.6%
Return on equity−30.4%0.18% (better)
Return on invested capital−25.0%−3.3% (better)
Financial health
Debt / equity0.20 (better)0.00
Current ratio1.301.96 (better)
Altman Z-score14.80 (better)2.88
Piotroski F-score45 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions29.1%12.8%
Held by insiders39.8%52.6%
Short interest, % of float0.98%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.